TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2021

Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133).

Stephen V Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.